TB-500 10mg is a recovery support peptide used to support tissue repair, recovery, and soft-tissue resilience. It is for people who want broader support for injury recovery, stubborn soft-tissue issues, and structured repair-focused protocols within The Clinic pen system. Supplied as a 10 mg cartridge in 2 mL, it provides a ready-to-use format for precise click-based dosing.
How It Works
TB-500 is a synthetic peptide associated with thymosin beta-4 activity and is commonly positioned around tissue recovery, cell migration, angiogenic signalling, and repair pathways. It is typically used where the goal is support for tissue regeneration, injury recovery, and improved recovery progression across muscle, tendon, ligament, and connective tissue support protocols.
| Pathway |
Primary Effect |
| Cell migration |
Supports tissue repair and recovery signalling |
| Angiogenic activity |
Associated with blood-vessel and healing-related support pathways |
| Soft-tissue recovery |
Used where the goal is broader tendon, ligament, muscle, and connective tissue support |
| Inflammatory balance |
Often positioned around recovery and healing support protocols |
Results and Outcomes
TB-500 is commonly used where the goal is faster recovery progression, improved tissue support, and broader healing support during or after injury. It is most often chosen for soft-tissue recovery protocols and more stubborn injury patterns where a wider recovery-support profile is preferred.
| Expected Outcome |
Practical Effect |
| Tissue repair support |
Used where the goal is broader recovery and repair progression |
| Soft-tissue support |
Supports tendon, ligament, muscle, and connective tissue protocols |
| Recovery support |
May assist during more intensive injury or repair-focused phases |
| Inflammation support |
Often included where tissue stress and recovery burden are elevated |
Dosage Protocol
Total strength: 10 mg / 2 mL
Concentration: 5 mg/mL
Pen system: 200 units
Per unit: 0.05 mg
Biological half-life: 2-3 days
Cycle guidance: A typical cycle lasts 4-8 weeks with an optional loading phase of higher doses for 1-2 weeks, then drop to standard dosage.
Suggested Dosage Table
| Units |
Dose |
Volume |
| 10 units |
0.25 mg |
0.10 mL |
| 20 units |
0.50 mg |
0.20 mL |
| 30 units |
0.75 mg |
0.30 mL |
| 40 units |
1.00 mg |
0.40 mL |
| 50 units |
1.25 mg |
0.50 mL |
| 60 units |
1.50 mg |
0.60 mL |
Recommended Dosage
| Use Case |
Dose |
Frequency |
Pen Equivalent |
| Starting |
1-1.25 mg |
Twice per week |
40-50 units per dose |
| Standard / Maintenance |
2-2.5 mg |
Twice per week |
80-100 units per dose |
| Advanced dose for stubborn injuries |
2.5-5 mg |
Twice per week |
100-200 units per dose |
Protocol Notes
| Guidance |
Detail |
| Starting phase |
Begin at the lower range before moving upward if needed |
| Standard use |
Most standard protocols sit in the 2-2.5 mg twice-weekly range |
| Optional loading phase |
Higher doses may be used for 1-2 weeks before dropping to standard dosage |
| Cycle length |
Typical use runs 4-8 weeks depending on recovery goals |
| Format |
Ready-to-use cartridge with no mixing required |
Warnings
| Warning |
Detail |
| Storage |
Keep refrigerated |
| Cycle duration |
Use shorter cycles first, then extend only where needed |
| Loading phase |
Higher-dose loading should be brief before reducing to standard dosage |
Related Products
| Product |
Use Case |
| BPC-157 |
Recovery-focused pairing |
| GHK-Cu |
Repair and skin-focused pairing |
| KPV |
Inflammation and GI-focused pairing |
| Reusable Pen Kit |
Required for cartridge-based use |
